Difference between revisions of "Upper tract urothelial carcinoma"
Jump to navigation
Jump to search
(create) |
|||
| Line 11: | Line 11: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | [[Category:Urothelium]] | ||
Revision as of 18:32, 3 September 2024
Upper tract urothelial carcinoma, is a urothelial carcinoma that involves the upper urinary tract (ureter, pelvis, kidney). It is a considered a rare disease.[1]
General
- Low-grade UCC may be managed via endoscopic approaches.[2]
- May be associated with Lynch syndrome - MMR testing typically indicated.
See also
References
- ↑ Kapoor A, Allard CB, Black P, Kassouf W, Morash C, Rendon R (2013). "Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma". Can Urol Assoc J 7 (9-10): 306–11. doi:10.5489/cuaj.1578. PMC 3854466. PMID 24319507. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854466/.
- ↑ Argyropoulos AN, Tolley DA (May 2007). "Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches". BJU Int 99 (5): 982–7. doi:10.1111/j.1464-410X.2007.06870.x. PMID 17437430.